Terms: = Pancreatic cancer AND NF2, ACN, 4771, ENSG00000186575, P35240, SCH, Merlin, BANF AND Treatment
10 results:
1. Detecting undetectable - epidemiology, etiology, and diagnosis of carcinoma of unknown primary - systematic review.
Ostojewska J; Wieczorek I; Pachciński O; Zdziennicki W; Burdan F
Folia Med Cracov; 2023 Apr; 63(1):19-37. PubMed ID: 37406274
[TBL] [Abstract] [Full Text] [Related]
2. Small molecule antagonist of CXCR2 and CXCR1 inhibits tumor growth, angiogenesis, and metastasis in pancreatic cancer.
Prajapati DR; Molczyk C; Purohit A; Saxena S; Sturgeon R; Dave BJ; Kumar S; Batra SK; Singh RK
Cancer Lett; 2023 Jun; 563():216185. PubMed ID: 37062329
[TBL] [Abstract] [Full Text] [Related]
3. Potential utility of cone-beam CT-guided adaptive radiotherapy under end-exhalation breath-hold conditions for pancreatic cancer.
Ogawa A; Nakamura M; Iramina H; Yoshimura M; Mizowaki T
J Appl Clin Med Phys; 2023 Feb; 24(2):e13827. PubMed ID: 36316795
[TBL] [Abstract] [Full Text] [Related]
4. Senescent Human pancreatic Stellate Cells Secrete CXCR2 Agonist CXCLs to Promote Proliferation and Migration of Human pancreatic cancer AsPC-1 and MIAPaCa-2 Cell Lines.
Takikawa T; Hamada S; Matsumoto R; Tanaka Y; Kataoka F; Sasaki A; Masamune A
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012531
[TBL] [Abstract] [Full Text] [Related]
5. Radiation-Induced Autophagy in Human pancreatic cancer Cells is Critically Dependent on G2 Checkpoint Activation: A Mechanism of Radioresistance in pancreatic cancer.
Suzuki M; Anko M; Ohara M; Matsumoto KI; Hasegawa S
Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):260-271. PubMed ID: 34112559
[TBL] [Abstract] [Full Text] [Related]
6. Role and mechanism of autophagy-regulating factors in tumorigenesis and drug resistance.
Usman RM; Razzaq F; Akbar A; Farooqui AA; Iftikhar A; Latif A; Hassan H; Zhao J; Carew JS; Nawrocki ST; Anwer F
Asia Pac J Clin Oncol; 2021 Jun; 17(3):193-208. PubMed ID: 32970929
[TBL] [Abstract] [Full Text] [Related]
7. The expression and phosphorylation of ezrin and merlin in human pancreatic cancer.
Zhou J; Feng Y; Tao K; Su Z; Yu X; Zheng J; Zhang L; Yang D
Int J Oncol; 2014 Jun; 44(6):2059-67. PubMed ID: 24728215
[TBL] [Abstract] [Full Text] [Related]
8. Insulin-like growth factor 1 receptor targeted therapeutics: novel compounds and novel treatment strategies for cancer medicine.
Hewish M; Chau I; Cunningham D
Recent Pat Anticancer Drug Discov; 2009 Jan; 4(1):54-72. PubMed ID: 19149688
[TBL] [Abstract] [Full Text] [Related]
9. Farnesyltransferase inhibitors--a novel approach in the treatment of advanced pancreatic carcinomas.
Dempke WC
Anticancer Res; 2003; 23(2A):813-8. PubMed ID: 12820305
[TBL] [Abstract] [Full Text] [Related]
10. [Phase II studies of interferon alpha-2 sch 30500 in advanced gastrointestinal carcinoma].
Furue H
Gan To Kagaku Ryoho; 1985 Aug; 12(8):1625-9. PubMed ID: 3896154
[TBL] [Abstract] [Full Text] [Related]
